Complete financial analysis of Chalice Brands Ltd. (CHAL.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Chalice Brands Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Fines inc. (5125.T) Income Statement Analysis – Financial Results
- Vision Corporation Limited (VISIONCO.BO) Income Statement Analysis – Financial Results
- Aoyama Trading Co., Ltd. (8219.T) Income Statement Analysis – Financial Results
- Aeon Fantasy Co., Ltd. (4343.T) Income Statement Analysis – Financial Results
- Axalta Coating Systems Ltd. (0U6C.L) Income Statement Analysis – Financial Results
Chalice Brands Ltd. (CHAL.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.chalicebrandsltd.com
About Chalice Brands Ltd.
Chalice Brands Ltd. engages in the retail, production, processing, wholesale, and distribution of cannabis products. It owns, operates, and manages a network of sixteen retail dispensaries in Oregon, including six operate under the flagship dispensary banner Chalice Farms; five operate under the banner of Homegrown Oregon; four under the banner of Cannabliss and Co; and one under the banner of Left Coast Connections. The company also provides Private Stash distillate vaporizer cartridges and single serve fruit chew blast product under the Golden and Chalice brands, as well as ethanol extract products under the RXO brand name and a live resin and distillate vaporizer cartridge under the brand name of Elysium Fields. In addition, it manufactures and sells oil products under the brand names Chalice, Golden, Private Stash, Elysium Fields, and Jackpot. The company was formerly known as Golden Leaf Holdings Ltd. and changed its name to Chalice Brands Ltd. in May 2021. Chalice Brands Ltd. is based in Toronto, Canada.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 21.91M | 15.75M | 16.45M | 11.51M | 7.66M | 9.93M | 0.00 |
| Cost of Revenue | 0.00 | 15.15M | 11.44M | 14.26M | 9.80M | 7.60M | 7.89M | 0.00 |
| Gross Profit | 0.00 | 6.76M | 4.32M | 2.19M | 1.71M | 65.88K | 2.04M | 0.00 |
| Gross Profit Ratio | 0.00% | 30.84% | 27.40% | 13.32% | 14.84% | 0.86% | 20.51% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 185.14K | 458.58K | 0.00 |
| General & Administrative | 0.00 | 9.39M | 12.03M | 19.05M | 9.93M | 8.70M | 11.92M | 21.23K |
| Selling & Marketing | 0.00 | 1.94M | 2.04M | 2.17M | 1.11M | 892.44K | 1.41M | 0.00 |
| SG&A | 0.00 | 11.33M | 14.07M | 21.21M | 11.05M | 9.60M | 13.33M | 21.23K |
| Other Expenses | 0.00 | 1.01M | 2.50M | 1.86M | 572.70K | 208.92K | -162.97K | 0.00 |
| Operating Expenses | 0.00 | 12.34M | 16.58M | 23.07M | 11.62M | 9.99M | 14.06M | 21.23K |
| Cost & Expenses | 0.00 | 27.49M | 28.01M | 37.33M | 21.42M | 17.59M | 21.95M | 21.23K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 2.28M | 2.71M | 2.22M | 1.55M | 1.22M | 131.37K | 6.84K |
| Depreciation & Amortization | 236.56K | 2.02M | 2.50M | 1.86M | 572.70K | 208.92K | 403.17K | 0.00 |
| EBITDA | 0.00 | -4.42M | -10.40M | -13.77M | -22.07M | -6.40M | -11.79M | -21.23K |
| EBITDA Ratio | 0.00% | -20.17% | -65.99% | -83.71% | -191.73% | -83.59% | -118.75% | 0.00% |
| Operating Income | 0.00 | -6.44M | -12.90M | -15.63M | -22.64M | -6.61M | -12.19M | -21.23K |
| Operating Income Ratio | 0.00% | -29.38% | -81.88% | -95.00% | -196.71% | -86.32% | -122.81% | 0.00% |
| Total Other Income/Expenses | 0.00 | -2.64M | -18.90M | 11.14M | -33.29M | -14.79M | -4.50M | -6.84K |
| Income Before Tax | 0.00 | -9.07M | -31.80M | -4.49M | -55.93M | -21.40M | -16.66M | -28.07K |
| Income Before Tax Ratio | 0.00% | -41.41% | -201.87% | -27.28% | -485.86% | -279.37% | -167.81% | 0.00% |
| Income Tax Expense | 0.00 | 955.60K | 812.46K | 82.81K | 143.23K | -74.14K | 800.69K | 0.00 |
| Net Income | 0.00 | -10.03M | -32.62M | -4.57M | -56.07M | -21.33M | -17.46M | -28.07K |
| Net Income Ratio | 0.00% | -45.77% | -207.03% | -27.78% | -487.11% | -278.40% | -175.87% | 0.00% |
| EPS | 0.00 | -0.26 | -1.12 | -0.18 | -4.92 | -5.38 | -7.21 | -0.01 |
| EPS Diluted | 0.00 | -0.26 | -1.12 | -0.18 | -4.92 | -5.38 | -7.21 | -0.01 |
| Weighted Avg Shares Out | 45.93M | 37.99M | 29.21M | 24.73M | 11.39M | 3.97M | 2.42M | 2.71M |
| Weighted Avg Shares Out (Dil) | 45.93M | 37.99M | 29.21M | 24.73M | 11.39M | 3.97M | 2.42M | 2.71M |
Source: https://incomestatements.info
Category: Stock Reports